Bicara Therapeutics Inc. (BCAX) vs Oric Pharmaceuticals, Inc. (ORIC)

Bicara Therapeutics Inc. and Oric Pharmaceuticals, Inc. are both Biotechnology companies. Bicara Therapeutics Inc. and Oric Pharmaceuticals, Inc. are of similar size ($1.4B and $1.3B). Across the 9 metrics below, Oric Pharmaceuticals, Inc. leads on 6 and Bicara Therapeutics Inc. on 3.

Valuation

Metric BCAX ORIC Biotechnology median
P/E n/m n/m 7.88
P/S n/m n/m 11.47
P/B 2.78 3.73 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m n/m 10.73
Earnings yield (16.14%) (10.26%) (28.84%)
Free cash flow yield (10.36%) (7.90%) (23.03%)

Profitability

Metric BCAX ORIC Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (41.01%) (39.80%) (57.72%)
Return on assets (38.38%) (37.35%) (49.22%)
Return on invested capital 0.00% (83.77%) 0.00%

Growth

Metric BCAX ORIC Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) 37.78% 19.67% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric BCAX ORIC Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 11.59 13.19 4.73
Net debt to EBITDA 2.67 1.95 0.96

Dividend

Metric BCAX ORIC Biotechnology median
Dividend yield — — 2.10%
Payout ratio — 0.00 0.00

Size

Metric BCAX ORIC Biotechnology median
Market cap 1.32b 1.37b 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack